Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Ferdinand Ploner
Observed names:
F. Ploner,
Ploner, Ferdinand
Institution:
Medical University of Graz
Observed institutions:
University of Graz,
Medical University of Graz,
Vienna General Hospital,
Graz University Hospital,
Universitätsklinik für Chirurgie Wien,
Medical University of Vienna
show all 6
OpenAlex ID:
A5113563590
Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study
2010
·
Rolf D Issels
, Lars H Lindner
, et al.
·
The Lancet Oncology
·
742
Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 5-year follow-up of the ABCSG-12 bone-mineral density substudy
2008
·
Michael Gnant
, Brigitte Mlineritsch
, et al.
·
The Lancet Oncology
·
412
Plasmapheresis reverses all side-effects of a cisplatin overdose – a case report and treatment recommendation
2006
·
Guenter Hofmann
, Thomas Bauernhofer
, et al.
·
BMC Cancer
·
187
PDF
Effects of infiltrating lymphocytes and estrogen receptor on gene expression and prognosis in breast cancer
2008
·
Alberto Calabrò
, Tim Beissbarth
, et al.
·
Breast Cancer Research and Treatment
·
136
Identification and meta‐analysis of a small gene expression signature for the diagnosis of estrogen receptor status in invasive ductal breast cancer
2006
·
Jörg Schneider
, Markus Ruschhaupt
, et al.
·
International Journal of Cancer
·
53
PDF
Risk stratification for venous thromboembolism in patients with testicular germ cell tumors
2017
·
Angelika Bezan
, Florian Posch
, et al.
·
PLoS ONE
·
46
PDF
Microsatellite analysis of breast carcinoma and corresponding local recurrences
2002
·
Peter Regitnig
, Renate Moser
, et al.
·
The Journal of Pathology
·
40
Pre-Treatment Anemia Is a Poor Prognostic Factor in Soft Tissue Sarcoma Patients
2014
·
Joanna Szkandera
, Armin Gerger
, et al.
·
PLoS ONE
·
39
PDF
Exemestane as primary systemic treatment for hormone receptor positive post-menopausal breast cancer patients: a phase II trial of the Austrian Breast and Colorectal Cancer Study Group (ABCSG-17)
2007
·
Brigitte Mlineritsch
, Christoph Tausch
, et al.
·
Breast Cancer Research and Treatment
·
39
Nuclear and cytoplasmic death receptor 5 as prognostic factors in patients with non-small cell lung cancer treated with chemotherapy
2008
·
Katharina Leithner
, Elvira Stacher
, et al.
·
Lung Cancer
·
35
Familial Cardiac Angiosarcoma
2006
·
Ingeborg M. Keeling
, Ferdinand Ploner
, et al.
·
The Annals of Thoracic Surgery
·
27
Bilateral carcinomas of the breast with local recurrence: analysis of genetic relationship of the tumors
2004
·
Peter Regitnig
, Ferdinand Ploner
, et al.
·
Modern Pathology
·
25
PDF
The course of serum HER-2/neu levels as an independent prognostic factor for survival in metastatic breast cancer
2004
·
Walter Schippinger
, Peter Regitnig
, et al.
·
Oncology Reports
·
22
The elevated pre‐operative plasma fibrinogen level is an independent negative prognostic factor for cancer‐specific, disease‐free and overall survival in soft‐tissue sarcoma patients
2013
·
Joanna Szkandera
, Martin Pichler
, et al.
·
Journal of Surgical Oncology
·
21
Rationale of a relaunch of gefitinib in Caucasian non-small cell lung cancer patients
2010
·
Andreas Pircher
, Ferdinand Ploner
, et al.
·
Lung Cancer
·
17
Konsensus Diagnose und Therapie von Weichteilsarkomen
2011
·
Thomas Brodowicz
, Gabriele Amann
, et al.
·
Wiener klinische Wochenschrift
·
16
Activity of regorafenib (RE) in leiomyosarcomas (LMS) and other types of soft-tissue sarcomas (OTS): Results of a double-blind, randomized placebo (PL) controlled phase II trial.
2015
·
Olivier Mir
, Thomas Brodowicz
, et al.
·
Journal of Clinical Oncology
·
15
Uric acid levels in blood are associated with clinical outcome in soft-tissue sarcoma patients
2014
·
Joanna Szkandera
, Armin Gerger
, et al.
·
Clinical Chemistry and Laboratory Medicine (CCLM)
·
15
The ethics of space, design and color in an oncology ward
2012
·
Elisabeth Andritsch
, Herbert Stöger
, et al.
·
Palliative & Supportive Care
·
15
Gastrointestinal stromal tumors: Diagnosis, therapy and follow-up care in Austria
2013
·
Evelyne Bareck
, Ahmed Ba-Ssalamah
, et al.
·
Wiener Medizinische Wochenschrift
·
12
Expertenempfehlung 2006 zur rationalen Zweitlinien-Therapie beim nicht-kleinzelligen Bronchuskarzinom
2007
·
Wolfgang Hilbe
, Kurt Aigner
, et al.
·
Wiener klinische Wochenschrift
·
12
Sorafenib in advanced, heavily pretreated patients with soft tissue sarcomas
2014
·
Kira Brämswig
, Ferdinand Ploner
, et al.
·
Anti-Cancer Drugs
·
11
Recommendations of the Austrian Working Group on Lung Pathology and Oncology for predictive molecular and immunohistochemical testing in non-small cell lung cancer
2013
·
Helmut H. Popper
, Ulrike Gruber-Moesenbacher
, et al.
·
memo - Magazine of European Medical Oncology
·
11
Histologie-basierter Algorithmus der molekularen Diagnostik des epidermalen Wachstumsfaktor-Rezeptorgens (Epidermal Growth Factor Receptor, EGFR) beim nicht-kleinzelligen Lungenkarzinom (non-small cell lung cancer, NSCLC)*
2011
·
und die Arbeitsgruppe Pulmopathologie der ÖGP-IAP
, Helmut Popper
, et al.
·
Wiener klinische Wochenschrift
·
8
Gastrointestinal stromal tumors: Recommendations on diagnosis, therapy and follow-up care in Austria
2009
·
Ferdinand Ploner
, Johannes Zacherl
, et al.
·
Wiener klinische Wochenschrift
·
4
Show more works
View as search
Works count:
38
Citation count:
1,965
H-index:
16
I10-index:
23
Year
Topic
Type